---
title: "Gold Surges 3%; Bristol-Myers Squibb Earnings Top Views"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294393295.md"
description: "U.S. stocks rose, with the Dow up over 200 points and NASDAQ surging 2.08%, driven by a 4.4% jump in technology shares. Bristol-Myers Squibb beat earnings expectations and raised guidance. Columbus McKinnon, Xerox, and Marketaxess saw significant gains on strong results or acquisition news. Conversely, Capricor Therapeutics and Alnylam dropped due to FDA setbacks and weak guidance. Gold surged 3% to $4,156.90, while oil fell slightly. European and Asian markets closed mostly higher."
datetime: "2026-07-30T16:02:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294393295.md)
  - [en](https://longbridge.com/en/news/294393295.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294393295.md)
---

# Gold Surges 3%; Bristol-Myers Squibb Earnings Top Views

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 200 points on Thursday.

The Dow traded up 0.40% to 51,801.63 while the NASDAQ surged 2.08% to 24,952.56. The S&P 500 also rose, gaining, 0.89% to 7,381.26.

**Leading and Lagging Sectors**

Information technology shares jumped by 4.4% on Thursday.

In trading on Thursday, communication services stocks fell by 3.2%.

**Top Headline**

**Bristol-Myers Squibb Co** (NYSE:BMY) posted better-than-expected earnings for the second quarter and raised its FY2026 guidance.

The company posted adjusted earnings of $2.04 per share, beating market estimates of $1.59 per share. The company’s sales came in at $12.973 billion, versus expectations of $11.745 billion.

**Equities Trading UP**           

-   **Columbus McKinnon Corp (NASDAQ:CMCO)** shares shot up 40% to $20.44 following upbeat quarterly results.
-   Shares of **Marketaxess Holdings Inc** (NASDAQ:MKTX) got a boost, surging 30% to $163.14 after Intercontinental Exchange announced it will acquire the company.
-   **Xerox Holdings Corp (**NASDAQ:XRX) shares were also up, gaining 39% to $3.67 after the company reported better-than-expected quarterly financial results.

**Equities Trading DOWN**

-   **Capricor Therapeutics Inc (**NASDAQ:CAPR) shares dropped 54% to $3.00 after the FDA Advisory Committee voted against its Deramiocel, an investigational cell therapy for Duchenne muscular dystrophy (DMD).
-   Shares of **Alnylam Pharmaceuticals, Inc. (**NASDAQ:ALNY) were down 27% to $209.70 after the company reported mixed second-quarter financial results and cut its FY26 sales guidance below estimates.
-   **Coastal Financial Corp** (NASDAQ:CCB) was down, falling 41% to $41.97 after the company reported second-quarter results.

**Commodities**  
  
In commodity news, oil traded down 0.3% to $84.18 while gold traded up 3% at $4,156.90.

Silver traded up 0.5% to $58.390 on Thursday, while copper rose 2.6% to $6.4725.

**Euro zone**

European shares were higher today. The eurozone’s STOXX 600 rose 0.9%, while Spain’s IBEX 35 Index gained 1.5% London’s FTSE 100 rose 0.3%, Germany’s DAX gained 0.5%, while France’s CAC 40 surged 1%.

**Asia Pacific Markets**

Asian markets closed mostly higher on Thursday, with Japan’s Nikkei 225 gaining 0.71%, Hong Kong’s Hang Seng index rising 0.20%, China’s Shanghai Composite falling 0.62% and India’s BSE Sensex gaining 0.35%.

**Economics**

-   U.S. personal income increased 0.2% month-over-month in June, down from market estimates of a 0.3% increase and easing from a 0.7% gain in May.
-   U.S. personal spending rose by 0.3% month-over-month in June, slowing from a revised 0.9% gain in May.
-   U.S. initial jobless claims rose by 9,000 to 197,000 in the week ending July 25, compared to market expectations of 200,000.
-   The U.S. PCE price index fell 0.1% month-over-month in June, following a 0.5% rise in May.
-   The U.S. economy grew by an annualized 1.5% in the second quarter, down from 2.1% in the first quarter and missing market estimates of 2.1%.

_Photo via Shutterstock_

### Related Stocks

- [XRX.US](https://longbridge.com/en/quote/XRX.US.md)
- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [CAPR.US](https://longbridge.com/en/quote/CAPR.US.md)
- [CMCO.US](https://longbridge.com/en/quote/CMCO.US.md)
- [MKTX.US](https://longbridge.com/en/quote/MKTX.US.md)
- [ALNY.US](https://longbridge.com/en/quote/ALNY.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [GLDM.US](https://longbridge.com/en/quote/GLDM.US.md)
- [IAU.US](https://longbridge.com/en/quote/IAU.US.md)
- [SCO.US](https://longbridge.com/en/quote/SCO.US.md)
- [BNO.US](https://longbridge.com/en/quote/BNO.US.md)
- [GLD.US](https://longbridge.com/en/quote/GLD.US.md)
- [.IXIC.US](https://longbridge.com/en/quote/.IXIC.US.md)
- [UGL.US](https://longbridge.com/en/quote/UGL.US.md)
- [GOLD.AU](https://longbridge.com/en/quote/GOLD.AU.md)
- [XLK.US](https://longbridge.com/en/quote/XLK.US.md)
- [SGOL.US](https://longbridge.com/en/quote/SGOL.US.md)
- [DIA.US](https://longbridge.com/en/quote/DIA.US.md)
- [DDM.US](https://longbridge.com/en/quote/DDM.US.md)
- [UDOW.US](https://longbridge.com/en/quote/UDOW.US.md)
- [DOG.US](https://longbridge.com/en/quote/DOG.US.md)
- [SDOW.US](https://longbridge.com/en/quote/SDOW.US.md)
- [DXD.US](https://longbridge.com/en/quote/DXD.US.md)
- [ROM.US](https://longbridge.com/en/quote/ROM.US.md)
- [TECL.US](https://longbridge.com/en/quote/TECL.US.md)
- [REW.US](https://longbridge.com/en/quote/REW.US.md)
- [TECS.US](https://longbridge.com/en/quote/TECS.US.md)
- [ONEQ.US](https://longbridge.com/en/quote/ONEQ.US.md)
- [QQQ.US](https://longbridge.com/en/quote/QQQ.US.md)
- [QQQM.US](https://longbridge.com/en/quote/QQQM.US.md)
- [QQEW.US](https://longbridge.com/en/quote/QQEW.US.md)
- [QQQE.US](https://longbridge.com/en/quote/QQQE.US.md)
- [TQQQ.US](https://longbridge.com/en/quote/TQQQ.US.md)
- [QLD.US](https://longbridge.com/en/quote/QLD.US.md)
- [PSQ.US](https://longbridge.com/en/quote/PSQ.US.md)
- [SQQQ.US](https://longbridge.com/en/quote/SQQQ.US.md)
- [QID.US](https://longbridge.com/en/quote/QID.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [ICE.US](https://longbridge.com/en/quote/ICE.US.md)
- [CCB.US](https://longbridge.com/en/quote/CCB.US.md)
- [00HSI.HK](https://longbridge.com/en/quote/00HSI.HK.md)
- [000001.CN](https://longbridge.com/en/quote/000001.CN.md)
- [CELG.RT.US](https://longbridge.com/en/quote/CELG.RT.US.md)
- [XRXDW.US](https://longbridge.com/en/quote/XRXDW.US.md)

## Related News & Research

- [FDA grants accelerated approval to Bristol Myers Squibb’s ZENBEXUS for relapsed multiple myeloma combo use](https://longbridge.com/en/news/295848217.md)
- [Bristol Myers wins ‘milestone’ FDA approval of myeloma drug acquired from Celgene](https://longbridge.com/en/news/296131073.md)
- [North Dakota State Investment Board Boosts Holdings in Bristol Myers Squibb Company $BMY](https://longbridge.com/en/news/296020226.md)
- [Bristol Myers Squibb Co. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains](https://longbridge.com/en/news/296268030.md)
- [Bristol Myers Squibb Gets FDA Nod For Novel Multiple Myeloma Treatment](https://longbridge.com/en/news/295957550.md)